Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Molecules ; 25(21)2020 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-33120888

RESUMEN

Epigenetic modifications play a key role in gene regulation and expression and are involved in numerous cellular processes. Due to the limited research on nucleosides in Parkinson's disease (PD), it is very important to consider epigenetic factors and their role in the development of PD. The aim of this study was to investigate and compare the levels of modified nucleosides, such as O-methylguanosine, N6-methyl-2'-deoxyadenosine, 1-methyladenosine, 1-methylguanine, 7-methylguanine, 3-methyladenine and 7-methylguanosine in the urine of Parkinson's disease (PD) patients and the control group, and to verify that the results obtained differ in a subgroup of patients with parkinsonian syndromes. The study group comprised 18 patients with diagnosed idiopathic Parkinson's disease and four parkinsonian syndromes. The control group consisted of 30 age- and sex-matched neurological patients without confirmation by neuroimaging brain damage and extrapyramidal symptoms. The levels of nucleosides were determined by validated liquid chromatography coupled with the mass spectrometry (LC-MS/MS) method using the multiple reaction monitoring (MRM) mode. Lower levels of O-methylguanosine, 3-methyladenine, 1-methylguanine, N6-methyl-2'-deoxyadenosine and a higher level of 7-methylguanine in the urine of 22 PD patients were observed. Moreover, elevated levels of 1-methyladenosine, 7-methylguanine, and O-methylguanosine were observed in the parkinsonian syndrome subgroup. These preliminary results may indicate that modified nucleosides describe metabolic disturbances in the metabolism of purine, which was the most severely affected pathway that mediated the detrimental effects of neuroinflammation on PD.


Asunto(s)
Cromatografía Liquida , Enfermedad de Parkinson/orina , Trastornos Parkinsonianos/orina , Espectrometría de Masas en Tándem , Urinálisis/métodos , Anciano , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad
2.
Neurology ; 86(11): 994-9, 2016 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-26865512

RESUMEN

OBJECTIVE: To test whether phosphorylated Ser-1292 LRRK2 levels in urine exosomes predicts LRRK2 mutation carriers (LRRK2+) and noncarriers (LRRK2-) with Parkinson disease (PD+) and without Parkinson disease (PD-). METHODS: LRRK2 protein was purified from urinary exosomes collected from participants in 2 independent cohorts. The first cohort included 14 men (LRRK2+/PD+, n = 7; LRRK2-/PD+, n = 4; LRRK2-/PD-, n = 3). The second cohort included 62 men (LRRK2-/PD-, n = 16; LRRK2+/PD-, n = 16; LRRK2+/PD+, n = 14; LRRK2-/PD+, n = 16). The ratio of Ser(P)-1292 LRRK2 to total LRRK2 was compared between LRRK2+/PD+ and LRRK2- in the first cohort and between LRRK2 G2019S carriers with and without PD in the second cohort. RESULTS: LRRK2+/PD+ had higher ratios of Ser(P)-1292 LRRK2 to total LRRK2 than LRRK2-/PD- (4.8-fold, p < 0.001) and LRRK2-/PD+ (4.6-fold, p < 0.001). Among mutation carriers, those with PD had higher Ser(P)-1292 LRRK2 to total LRRK2 than those without PD (2.2-fold, p < 0.001). Ser(P)-1292 LRRK2 levels predicted symptomatic from asymptomatic carriers with an area under the receiver operating characteristic curve of 0.844. CONCLUSION: Elevated ratio of phosphorylated Ser-1292 LRRK2 to total LRRK2 in urine exosomes predicted LRRK2 mutation status and PD risk among LRRK2 mutation carriers. Future studies may explore whether interventions that reduce this ratio may also reduce PD risk.


Asunto(s)
Heterocigoto , Trastornos Parkinsonianos/genética , Trastornos Parkinsonianos/orina , Fenotipo , Proteínas Serina-Treonina Quinasas/genética , Proteínas Serina-Treonina Quinasas/orina , Anciano , Animales , Biomarcadores/orina , Estudios de Cohortes , Estudios Transversales , Células HEK293 , Humanos , Proteína 2 Quinasa Serina-Treonina Rica en Repeticiones de Leucina , Masculino , Ratones , Persona de Mediana Edad , Trastornos Parkinsonianos/diagnóstico , Fosforilación/fisiología , Proyectos Piloto
4.
J Trace Elem Med Biol ; 28(3): 338-43, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24867657

RESUMEN

Chronic exposure even to low doses of manganese may lead to development of neurological syndrome similar to parkinsonism. The aim of this research is to assess the possibility of manganese poisoning based on the level of metal in the urine of long-term methcathinone users from Poland. Graphite furnace atomic absorption spectroscopy (GFAAS) was used to determine manganese in urine, while the detection of the psychoactive drugs was performed by high-performance liquid chromatography (HPLC). Results of survey on longitudinal patterns of drug use showed that users of traditional illicit drugs now turn to cheaper alternatives, such as methcathinone. Parkinsonian features were observed in almost half of methcathinone users. The subjects had a higher mean level of Mn in their urine (8.68±9.27 µg L(-1)) than the controls (4.27±1.91 µg L(-1)). The presence of numerous psychoactive substances (in unchanged forms and their metabolites) was confirmed in all of the samples, with only one exception. The elevated level of manganese in urine (in 29.2% of patients) can be used as a primary marker of recent methcathinone administration, especially in the case of long time intravenous drug users where blood sampling is complicated.


Asunto(s)
Manganeso/orina , Propiofenonas/administración & dosificación , Humanos , Trastornos Parkinsonianos/orina , Espectrofotometría Atómica
5.
J Cell Physiol ; 226(5): 1390-8, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-20945350

RESUMEN

Increased oxidative stress contributes to pathogenesis of Parkinson's disease (PD). 8-hydroxy-2'-deoxyguanosine (8-OHdG) is the oxidation product most frequently measured as an indicator of oxidative DNA damage. Several studies have shown increased 8-OHdG in PD patients. There are few basic laboratory data examining 8-OHdG levels in animal models of PD. In this study, we utilized hemiparkinsonian model of rats induced by intrastriatal injection of 6-hydroxydopamine (6-OHDA). The urinary 8-OHdG level was measured in relation to behavioral and pathological deficits arising from 6-OHDA-induced neurotoxic effects on the nigrostriatal dopaminergic pathway. All rats were subjected to a series of behavioral tests for 42 days after 6-OHDA injection. We collected urine samples with subsequent measurement of 8-OHdG level using ELISA kits. For immunohistochemical evaluation, tyrosine hydroxylase (TH) staining was performed. Significant increments in urinary 8-OHdG level were observed continuously from day 7 until day 35 compared to control group, which showed a trend of elevation as early as day 3. Such elevated urinary 8-OHdG level significantly correlated with all of the behavioral deficits measured here, suggesting that urinary 8-OHdG level provides a good index of severity of parkinsonism. Urinary 8-OHdG level also had a significant positive correlation with the survival rate of dopaminergic fibers or neurons, advancing the concept that oxidative stress during the early phase of 6-OHDA neurotoxicity may correspond to disease progression closely approximating neuronal degeneration in the nigrostriatal dopaminergic system. The present results demonstrate that alterations in urinary 8-OHdG level closely approximate onset and disease progression in PD.


Asunto(s)
Ganglios Basales/metabolismo , Conducta Animal , Encéfalo/metabolismo , Desoxiguanosina/análogos & derivados , Dopamina/metabolismo , Degeneración Nerviosa/metabolismo , Trastornos Parkinsonianos/metabolismo , Sustancia Negra/metabolismo , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Ganglios Basales/patología , Biomarcadores/orina , Encéfalo/patología , Desoxiguanosina/orina , Modelos Animales de Enfermedad , Progresión de la Enfermedad , Ensayo de Inmunoadsorción Enzimática , Femenino , Inmunohistoquímica , Inyecciones , Actividad Motora , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/patología , Degeneración Nerviosa/psicología , Degeneración Nerviosa/orina , Estrés Oxidativo , Oxidopamina/administración & dosificación , Trastornos Parkinsonianos/inducido químicamente , Trastornos Parkinsonianos/patología , Trastornos Parkinsonianos/psicología , Trastornos Parkinsonianos/orina , Ratas , Ratas Sprague-Dawley , Índice de Severidad de la Enfermedad , Sustancia Negra/patología , Factores de Tiempo , Tirosina 3-Monooxigenasa/metabolismo
6.
Mov Disord ; 24(1): 123-6, 2009 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-18972548

RESUMEN

Amyotrophic lateral sclerosis and Parkinsonism-dementia complex of the Kii peninsula (Kii ALS/PDC) is an endemic and a tauopathy, which shows clinical symptoms of amyotrophy, parkinsonism, and dementia. The objective of this study was to report the role of oxidative stress on Kii ALS/PDC using biochemical analysis. Urinary 8-hydroxydeoxyguanosine (8-OHdG)/creatinine ratio was analyzed in 11 patients with Kii ALS/PDC and 8 normal controls. The mean level of urinary 8-OHdG/creatinine ratio of the patients with Kii ALS/PDC was significantly higher than that of control subjects. Oxidative stress may be implicated in pathogenesis of Kii ALS/PDC.


Asunto(s)
Esclerosis Amiotrófica Lateral/metabolismo , Estrés Oxidativo , Trastornos Parkinsonianos/metabolismo , Tauopatías/metabolismo , Anciano , Anciano de 80 o más Años , Esclerosis Amiotrófica Lateral/epidemiología , Esclerosis Amiotrófica Lateral/orina , Creatinina/uso terapéutico , Enfermedades Endémicas , Femenino , Guanosina/análogos & derivados , Guanosina/orina , Humanos , Japón/epidemiología , Masculino , Trastornos Parkinsonianos/epidemiología , Trastornos Parkinsonianos/orina , Índice de Severidad de la Enfermedad , Tauopatías/epidemiología , Tauopatías/orina
7.
Brain Res ; 1133(1): 49-52, 2007 Feb 16.
Artículo en Inglés | MEDLINE | ID: mdl-17188662

RESUMEN

8-Hydroxy-2'-deoxyguanosine (8-OHdG), the predominant marker of oxidative DNA damage, may be a good biomarker for monitoring the progression of Parkinson's disease (PD). Unfortunately, there are no basic laboratory data examining 8-OHdG levels in animal models of PD. In this study, we demonstrate that rats lesioned with 6-hydroxydopamine (6-OHDA) in the medial forebrain bundle display significantly elevated 8-OHdG levels in urine, serum, and substantia nigra, but not cerebrospinal fluid and striatum, compared to sham controls. These increments in 8-OHdG levels were detected at 2 days, but not at 7 days after the lesion suggesting that oxidative stress is restricted to the acute phase of 6-OHDA neurotoxicity. The present results support 8-OHdG as a biomarker that may aid both in the diagnosis and in the documentation of progression in PD.


Asunto(s)
Desoxiguanosina/análogos & derivados , Estrés Oxidativo , Trastornos Parkinsonianos/sangre , Trastornos Parkinsonianos/orina , Sustancia Negra/metabolismo , Regulación hacia Arriba , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Biomarcadores/sangre , Biomarcadores/metabolismo , Biomarcadores/orina , Desoxiguanosina/sangre , Desoxiguanosina/metabolismo , Desoxiguanosina/orina , Progresión de la Enfermedad , Neurotoxinas , Oxidopamina , Trastornos Parkinsonianos/fisiopatología , Ratas , Ratas Sprague-Dawley , Sustancia Negra/fisiopatología , Factores de Tiempo
8.
J Neurol Sci ; 248(1-2): 23-30, 2006 Oct 25.
Artículo en Inglés | MEDLINE | ID: mdl-16765382

RESUMEN

BACKGROUND: Involvement of metals in the risk of developing Parkinson's disease (PD) has been suggested. In the present study, concentration of metals in cerebrospinal fluid (CSF), blood, serum, urine and hair of 91 PD patients and 18 controls were compared. METHODS: Blood and hair were microwave digested, while CSF, serum and urine were water-diluted. Elements quantification was achieved by Inductively Coupled Plasma Atomic Emission Spectrometry and Sector Field Inductively Coupled Plasma Mass Spectrometry. RESULTS: Some metal imbalances in PD were observed: i), in CSF, lower Fe and Si; ii), in blood, higher Ca, Cu, Fe, Mg and Zn; iii), in serum, lower Al and Cu; iv), in urine, lower Al and Mn, higher Ca and Fe; and v), in hair, lower Fe. The ROC analysis suggested that blood Ca, Fe, Mg and Zn were the best discriminators between PD and controls. In addition, hair Ca and Mg were at least 1.5 times higher in females than in males of patients and controls. A decrement with age of patients in hair and urine Ca and, with less extent, in urine Si was observed. Magnesium concentration in CSF decreased with the duration and severity of the disease. Elements were not influenced by the type of antiparkinsonian therapy. CONCLUSIONS: Variation in elements with the disease do not exclude their involvement in the neurodegeneration of PD.


Asunto(s)
Metales/sangre , Metales/líquido cefalorraquídeo , Trastornos Parkinsonianos/sangre , Trastornos Parkinsonianos/inducido químicamente , Factores de Edad , Anciano , Anciano de 80 o más Años , Femenino , Cabello/metabolismo , Humanos , Masculino , Metales/orina , Persona de Mediana Edad , Trastornos Parkinsonianos/orina , Curva ROC , Espectrofotometría Atómica/métodos , Estadísticas no Paramétricas
9.
Bull Exp Biol Med ; 130(8): 805-9, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11177250

RESUMEN

The content of catecholamines and their metabolites in the brain and the relationship between cerebral catecholamine levels and their urinary excretion were studied in rats with 6-OHDA-induced hemiparkinsonism. 6-OHDA reduced brain concentrations of dopamine, DOPAC, and homovanilic acid and urinary excretion of dopamine, dioxyphenilalanine, and DOPAC by more than 90%. A positive correlation was found between the concentrations of these metabolites in the urine and striatum. Measurement of urinary catecholamines and their metabolites is a perspective test for evaluating the status of the dopaminergic nigrosostriate system of the brain in experimental parkinsonism.


Asunto(s)
Encéfalo/metabolismo , Catecolaminas/metabolismo , Metoxihidroxifenilglicol/análogos & derivados , Trastornos Parkinsonianos/metabolismo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Ácido 3,4-Dihidroxifenilacético/orina , Animales , Encéfalo/patología , Catecolaminas/orina , Dihidroxifenilalanina/metabolismo , Dihidroxifenilalanina/orina , Dopamina/metabolismo , Dopamina/orina , Epinefrina/metabolismo , Epinefrina/orina , Ácido Homovanílico/metabolismo , Ácido Homovanílico/orina , Masculino , Metoxihidroxifenilglicol/metabolismo , Metoxihidroxifenilglicol/orina , Norepinefrina/metabolismo , Norepinefrina/orina , Oxidopamina/toxicidad , Trastornos Parkinsonianos/inducido químicamente , Trastornos Parkinsonianos/patología , Trastornos Parkinsonianos/orina , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA